As of January 2026, the US Percutaneous Coronary Intervention (PCI) market is identifying as a high-tech powerhouse within the cardiovascular sector, with a valuation estimated to reach approximately $3.2 billion this year. The 2026 landscape is defined by a significant rebound in procedure volumes, which have now surpassed 1,000,000 annual cases across the United States. This 2026 milestone is...